AEG -1 overexpression: A novel indicator for peritoneal dissemination and lymph node metastasis in epithelial ovarian cancers

International Journal of Gynecological Cancer

Volumn 21, Issue 4, 2011, Pages 602-608

  Li, Cong ^a   Liu, Junjun ^a   Lu, Renbo ^a   Yu, Ge ^a   Wang, Xiaochuan ^a   Zhao, Yulan ^a   Song, Hongtao ^a   Lin, Ping ^a   Sun, Xicai ^a   Yu, Xiaoguang ^a   Zhang, Yuan ^a   Ning, Xiaoming ^a   Geng, Jingshu ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Astrocyte elevated geneY1; Epithelial ovarian cancer; Lymph node metastasis; Peritoneal dissemination

Indexed keywords

CELL PROTEIN; PROTEIN AEG 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER SURGERY; CONTROLLED STUDY; EPITHELIAL OVARIAN CANCER; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVARY CANCER; PERITONEUM METASTASIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; CELL ADHESION MOLECULES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 80051879660     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e3182145561     Document Type: Article

References (39)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300.
2. Kikkawa F, Kawai M, Mizuno K, et al. Recurrence of epithelial ovarian carcinoma after clinical remission. Gynecol Obstet Invest. 1994;38:65-69. (Pubitemid 24203873)
3. Hoskins WJ, Perez CA, Young RC. Principles and Practice of Gynecologic Oncology. Philadelphia, PA: Lippincott Williams and Wilkins; 2000:1005-1007.
4. Brown DM, Ruoslahti E. Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell. 2004;5:365-374. (Pubitemid 38482072)
5. Thirkettle HJ, Girling J, Warren AY, et al. LYRIC/AEG-1 is targeted to different subcellular compartments by ubiquitinylation and intrinsic nuclear localization signals. Clin Cancer Res. 2009;15:3003-3013.
6. Thirkettle HJ, Mills IG, Whitaker HC, et al. Nuclear lyric/AEG-1 interacts with PLZF and relives PLZF-mediated repression. Oncogene. 2009;28:3663-3670.
7. Su ZZ, Kang DC, Chen Y, et al. Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH. Oncogene. 2002;21:3592-3602. (Pubitemid 34587691)
8. Yoo BK, Emdad L, Lee SG, et al. Astrocyte elevated geneY1 (AEG-1): a multifunctional regulator of normal and abnormal physiology. Pharmacol Ther. In press.
9. Hu G, Chong RA, Yang Q, et al. MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor prognosis breast cancer. Cancer Cell. 2009;15:9-20.
10. Kang DC, Su ZZ, Sarkar D, et al. Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene. 2005;353:8-15. (Pubitemid 40805356)
11. Lee SG, Su ZZ, Emdad L, et al. Astrocyte elevated geneY1 activates cell survival pathways through PI3K-Akt signaling. Oncogene. 2008;27:1114-1121. (Pubitemid 351253177)
12. Lee SG, Su ZZ, Emdad L, et al. Astrocyte elevated geneY1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phospha-tidylinositol 3-kinase and c-Myc. Proc Natl Acad Sci USA. 2006;14:17390-17395. (Pubitemid 44788979)
13. Kikuno N, Shiina H, Urakami S, et al. Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene. 2007;26:7647-7655. (Pubitemid 350224215)
14. Yoo BK, Emdad L, Su ZZ, et al. Astrocyte elevated geneY1 regulates hepatocellular carcinoma development and progression. J Clin Invest. 2009;119:465-477.
15. Emdad L, Sarkar D, Su ZZ, et al. Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis. Cancer Res. 2006;66:1509-1516. (Pubitemid 43259932)
16. Emdad L, Sarkar D, Su ZZ, et al. Astrocyte elevated geneY1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration. Pharmacol Ther. 2007;114:155-170. (Pubitemid 46561534)
17. Liu L, Wu J, Ying Z, et al. Astrocyte elevated geneY1 upregulates matrix metalloproteinase-9 and induces human glioma invasion. Cancer Res. 2010;70:3750-3759.
18. Sarkar D, Park ES, Emdad L, et al. Molecular basis of nuclear factor-kappaB activation by astrocyte elevated geneY1. Cancer Res. 2008;68:1478-1484. (Pubitemid 351346856)
19. Emdad L, Lee SG, Su ZZ, et al. Astrocyte elevated geneY1 (AEG-1) functions as an oncogene and regulates angiogenesis. Proc Natl Acad Sci U S A. 2009;106:21300-21305.
20. Emdad L, Sarkar D, Lee SG, et al. Astrocyte elevated geneY1: a novel target for human glioma therapy. Mol Cancer Ther. 2010;9:79-88.
21. Yoo BK, Chen D, Su ZZ, et al. Molecular mechanism of chemoresistance by astrocyte elevated gene-1. Cancer Res. 2010;70:3249-3258.
22. Liu H, Song X, Liu C, et al. Knockdown of astrocyte elevated geneY1 inhibits proliferation and enhancing chemo-sensitivity to cisplatin or doxorubicin in neuroblastoma cells. J Exp Clin Cancer Res. 2009;28:19.
23. Yoo BK, Gredler R, Vozhilla N, et al. Identification of genes conferring resistance to 5-fluorouracil. Proc Natl Acad Sci USA. 2009;106:12938-12943.
24. Hongtao S, Cong L, Renbo L, et al. Expression of AEG-1: a novel marker of the pathogenesis, progression and poor prognosis for endometrial cancer. Int J Gynecol Cancer. 2010;20:1188-1196.
25. Hongtao S, Cong L, Rui L, et al. Prognostic significance of AEG-1 expression in colorectal carcinoma. Int J Colorectal Dis. 2010;25:1201-1209.
26. Cong L, Rui L, Hongtao S, et al. Significance of AEG-1 expression in correlation with VEGF, microvessel density (MVD) and clinicopathological characteristics in triple-negative breast cancer. J Surg Oncol. 2011;103:184-192.
27. Sarkar D, Emdad L, Lee SG, et al. Astrocyte elevated geneY1: far more than just a gene regulated in astrocytes. Cancer Res. 2009;69:8529-8535.
28. Li J, Yang L, Song L, et al. Astrocyte elevated geneY1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1. Oncogene. 2009;28:3188-3196.
29. Hu G, Wei Y, Kang Y. The multifaceted role of MTDH/AEG-1 in cancer progression. Clin Cancer Res. 2009;15:5615-5620.
30. Meng F, Luo C, Ma L, et al. Clinical significance of astrocyte elevated gene-1 expression in human epithelial ovarian carcinoma. Int J Gynecol Pathol. 2011;30:145-150.
31. Xia Z, Zhang N, Jin H, et al. Clinical significance of astrocyte elevated geneY1 expression in human oligodendrogliomas. Clin Neurol Neurosurg. 2010;112:413-419.
32. Chen W, Ke Z, Shi H, et al. Overexpression of AEG-1 in renal cell carcinoma and its correlation with tumor nuclear grade and progression. Neoplasma. 2009;57:522-529.
33. Xu JB, Wu H, He YL, et al. Astrocyte-elevated geneY1 overexpression is associated with poor prognosis in gastric cancer. Med Oncol. 2011;130:1-8.
34. Jeon HY, Choi M, Howlett EL, et al. Expression patterns of astrocyte elevated geneY1 (AEG-1) during development of the mouse embryo. Gene Expr Patterns. 2010;10:361-367.
35. Anttila V, Stefansson H, Kallela M, et al. Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat Genet. 2010;42:869-873.
36. Noch E, Bookland M, Khalili K. Astrocyte-elevated gene-1 (AEG-1) induction by hypoxia and glucose deprivation in glioblastoma. Cancer Biol Ther. 2011;11:32-39.
37. Carnemolla A, Fossale E, Agostoni E, et al. Rrs1 is involved in endoplasmic reticulum stress response in Huntington disease. J Biol Chem. 2009;284:18167-18173.
38. Scully R. Histological Typing of Ovarian Tumors (WHO. World Health Organization. International Histological Classification of Tumours). Berlin, Germany: Springer; 1999.
39. Benedet JL, Bender H, Jones H, et al. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet. 2000;70:209-262.